Legend Capital was among the investors in the synthetic biology-derived materials producer’s fourth round, which helped lift its total funding to over $100m.

MUFG Innovation Partners contributed to mobility financier Moove's $105m series A2 round while MS&AD and Nationwide helped insurance software developer Socotra raise $50m.

SAIC Motor’s Hengxu Capital helped allosteric drug developer Nutshell Therapeutics close a $40m round while cancer therapy developer Impact Therapeutics secured series D1 funding.

Lunar expanded its series D round to $307m while RefleXion Medical raised $80m and Silent Eight raked in $40m.

Animoca Brands and Untamed Planet have stepped out of the crypto and gaming sphere to invest in a genetic engineering startup looking to bring back the woolly mammoth.

GV and Animoca Brands helped earphone developer Nothing secure $70m while Cialfo bumped its Seek-backed series B round up to $60m.

Eli Lilly, Johnson & Johnson Innovation – JJDC, Pfizer Ventures and Alexandria Venture Investments all returned for the $26m second tranche of the immunobiology therapy developer’s series A round.

JPMorgan Chase and Salesforce Ventures took part in financial services provider Propel's $50m series B round while prayer app developer Glorify closed its second $40m round in three months.

STV co-led a $54m extension lifting BNPL service Tabby's series B round to $104m while online seafood marketplace Captain Fresh doubled its valuation to $500m in a $50m series C.

Optum Ventures has led the latest round for the health plan administration platform, investing together with Cigna Ventures to take its overall funding to $40m.